Categories
Specials
Brand: BIOMED
Product Code: 11301
Price: 164EGP
Ex Tax: 164EGP
Rate this product

Example

Returns

You can return the product within 14 days of purchase.

Returns

You can return the product within 14 days of purchase.

Custom block

BIOLEGAM 50 / 30 MG ( SILDENAFIL / DAPOXETINE ) 8 FILM-COATED TABLETS

Clinical trials and meta-analyses show:

  • The combination improves International Index of Erectile Function (IIEF) scores significantly.
  • Increases intravaginal ejaculatory latency time (IELT) more than dapoxetine alone.
  • Improves patient satisfaction and relationship outcomes.
  • Side effects are predictable and dose-dependent.

(Sources include urology journals, sexual medicine reviews, and safety data extrapolated from BNF, UpToDate, and product monographs for each drug.)

Sildenafil + Dapoxetine (Oral Combination) – Medical Description:
1. Clinical Classification

A fixed-dose oral combination containing:

►Sildenafil — Phosphodiesterase-5 (PDE-5) inhibitor
Indicated for erectile dysfunction (ED)

►Dapoxetine — Short-acting selective serotonin reuptake inhibitor (SSRI)
Indicated for premature ejaculation (PE)

This combination is used in men who have both ED and PE simultaneously, allowing a single on-demand dose.

2. Mechanism of Action

Sildenafil

  • Inhibits PDE-5 → increases cGMP levels in corpus cavernosum
  • Produces smooth muscle relaxation and improves penile blood flow
  • Requires sexual stimulation to work

Dapoxetine

  • Inhibits serotonin reuptake in the CNS
  • Enhances serotonergic activity in the ejaculatory reflex control center
  • Increases ejaculatory latency, improves control, and reduces distress

Combined Effect

  • Improves erection quality + delays ejaculation
  • Designed for men with dual sexual dysfunction
  • Taken on-demand, typically 1–3 hours before intercourse

3. Therapeutic Indications

Used for:

  • Erectile dysfunction with premature ejaculation occurring together
  • Men who did not respond adequately to individual therapies or prefer combination treatment

(Note: No FDA- or EMA-approved fixed combination; but widely studied and used in some markets. Clinical rationale is supported by multiple peer-reviewed trials.)

4. Pharmacokinetics (Key Points)
Sildenafil Component

  • Onset: 30–60 min
  • Duration: 4–6 hours
  • Metabolism: CYP3A4

Dapoxetine Component

  • Onset: 1–3 hours
  • Very short half-life → suitable for on-demand use
  • Metabolism: CYP2D6 + CYP3A4

Combined: Both drugs peak around the time of sexual activity.

5. Standard Adult Dose

Typical fixed-dose combinations include:

  • Sildenafil 50 mg + dapoxetine 30 mg
  • Sildenafil 100 mg + dapoxetine 60 mg

Taken once daily maximum, 1–3 hours before sexual activity.

6. Safety Profile

Common Side Effects:

  • Headache
  • Flushing
  • Dizziness
  • Nausea (very common with dapoxetine)
  • Nasal congestion
  • Diarrhea
  • Insomnia
  • Palpitations or mild tachycardia

Potential Serious Side Effects:

  • Marked hypotension (additive effect of both drugs)
  • Syncope (fainting) — more associated with dapoxetine
  • Priapism (rare; due to sildenafil)
  • Serotonin syndrome (if used with serotonergic drugs)
  • Visual disturbances

7. Contraindications

Combination is not recommended when any of the following apply:

Absolute

  • Concurrent nitrate therapy (risk of severe hypotension)
  • MAO inhibitors or thioridazine (due to dapoxetine)
  • SSRIs/SNRIs/TCAs or other serotonergic drugs
  • Severe liver impairment
  • Severe cardiac conditions (recent MI, unstable angina, heart failure)
  • History of syncope or significant orthostatic hypotension

Cautions

  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin, ritonavir)
  • Hypertension or hypotension
  • Diabetes with cardiovascular risk
  • Elderly patients

8. Drug Interactions

Major interactions:

  • Nitrates → dangerous hypotension
  • Alpha-blockers → exaggerated hypotensive effect
  • SSRIs/SNRIs/TCAs/MAOIs → serotonin syndrome
  • CYP3A4 inhibitors → increased levels of both components
  • Alcohol → increases dizziness and risk of fainting
  • Informational Purposes: All information provided is for educational and informational purposes only.
  • Not Professional Advice: This content does not constitute professional medical advice, diagnosis, or treatment.
  • Consult Your Physician: Always seek the advice of your physician or another qualified healthcare provider with any questions you may have regarding a medical condition or the use of this medication.
  • Reliability of Information: While information is derived from reputable sources, it may not reflect the most current medical research or the latest FDA labeling changes. 

 

Write a review

Your Name:


Your Review: (optional) Text is optional. Maximum 1,000 characters. Reviews are published automatically after validation.

Rating: Bad           Good

Enter the code in the box below:



Related Products (27)